BioSyent Inc.
BIOYF
$8.50
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.51% | -9.76% | 40.27% | -31.90% | 46.51% |
| Total Depreciation and Amortization | 68.86% | -24.11% | -57.30% | 293.23% | -3.71% |
| Total Amortization of Deferred Charges | -184.49% | 1,290.63% | 357.14% | -- | -- |
| Total Other Non-Cash Items | -95.38% | -224.20% | -92.62% | 461.90% | 2.00% |
| Change in Net Operating Assets | -105.00% | 140.17% | -778.74% | -89.24% | 236.40% |
| Cash from Operations | -19.87% | 601.16% | -126.77% | -61.36% | 538.44% |
| Capital Expenditure | 168.15% | 2.88% | 40.34% | -153.26% | -53.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.18% | -82.05% | -40.32% | 134.86% | -170.34% |
| Cash from Investing | 163.82% | -83.51% | 19.34% | 117.08% | -170.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.92% | -1.05% | -1.93% | -1.30% | -0.88% |
| Issuance of Common Stock | 446.03% | -89.23% | -63.93% | 223.11% | 32.11% |
| Repurchase of Common Stock | 28.51% | 97.54% | 74.78% | -16,515.79% | 93.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.52% | -3.62% | -7.12% | 4.16% | -0.37% |
| Other Financing Activities | 3.97% | 3.82% | 6.43% | 4.11% | 2.67% |
| Cash from Financing | 4.82% | 56.31% | 64.68% | -637.69% | 39.06% |
| Foreign Exchange rate Adjustments | 202.00% | -900.00% | -102.24% | 217.99% | -9,550.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.14% | 367.90% | -69.34% | -166.27% | -79.19% |